BioPharmSignal logoBioPharmSignal

Biotech News

Teladoc Health Reports Third Quarter 2026 Results

Teladoc (TDOC)TeladocEarnings

Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended September 30, 2026 (“Third Quarter 2026”). Unless otherwise noted, percentage and other changes are relative to the three months ended September 30, 2025 (“Third Quarter 2025”).

Related news

TDOCTeladoc2026-10-14 20:05 EST

Teladoc Health to Announce Third Quarter 2026 Financial Results

TDOCTeladoc2025-10-29 20:05 EST

Teladoc Health Reports Third Quarter 2025 Results

HSTMHealthStream2026-11-02 21:30 EST

HealthStream Announces Third Quarter 2026 Results

HSTMHealthStream2026-10-26 13:25 EST

HealthStream to Host Third Quarter 2026 Earnings Conference Call

PGNYProgyny2026-10-21 14:43 EST

Progyny, Inc. Announces Details for Its Third Quarter 2026 Results Report

PGNYProgyny2026-07-23 19:30 EST

Progyny, Inc. Announces Details for Its Second Quarter 2026 Results Report

View all latest news

Teladoc

Virtual Care Platform Teladoc Health provides technology-enabled healthcare through virtual visits, digital programs, and connected-care tools. Its platform links patients with clinicians across general medical care, specialty services, chronic-condition management, and mental health. Integrated Care Segment Integrated Care serves health...

Recent company news

TDOCTeladoc2026-10-28 20:05 EST

Teladoc Health Reports Third Quarter 2026 Results

TDOCTeladoc2026-10-14 20:05 EST

Teladoc Health to Announce Third Quarter 2026 Financial Results

TDOCTeladoc2026-10-07 10:00 EST

Teladoc Health Expands Solo Connected Care Platform with AI-Powered Capabilities to Help Hospitals Scale Smarter Care Delivery

TDOCTeladoc2026-09-25 12:30 EST

Teladoc Health Announces Chief Legal Officer Transition

TDOCTeladoc2026-09-03 20:35 EST

Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08

Stock data

Close
9.41 USD
Market cap
1.36B USD
Exchange
NYSE
Sector
Biopharma
Location
United States